长三角数字健康产业链联盟成立,打造“长三角健共体”助力一体化发展”

2020-10-06 动脉网 动脉网

为进一步推动落实长三角一体化,引导产业链集群协同发展,近日,长三角企业家圆桌会议在上海举行。会上,长三角数字健康产业链联盟正式成立,由微医集团、浙江大学、邵逸夫医院、华为云等68家单位共同组建,搭建产

为进一步推动落实长三角一体化,引导产业链集群协同发展,近日,长三角企业家圆桌会议在上海举行。会上,长三角数字健康产业链联盟正式成立,由微医集团、浙江大学、邵逸夫医院、华为云等68家单位共同组建,搭建产、学、研、用的开放平台,打造长三角一体化数字医疗健康服务共同体(下称“长三角健共体”),提升长三角卫生健康水平,加快推动长三角数字健康产业发展。

长三角数字健康产业链联盟,是长三角企业家联盟下设的四大产业链联盟之一,总部位于杭州。该联盟由微医集团担任理事长单位,并联合浙江大学、复旦大学、南京大学、中国科学技术大学等知名高校,上海华山医院、上海瑞金医院、浙江大学医学院附属邵逸夫医院、江苏省人民医院等知名三甲医院,以及腾讯云、阿里云、华为云、移动云等67家单位共同组建,覆盖医疗、医药、保险、医养、金融、数字技术等全产业链条。

数字健康联盟成立后,将充分发挥长三角医疗高地、数字健康全产业链发展的优势,重点打造“长三角健共体”,其中计划落地长三角互联网医保大健康服务平台,通过统一平台实现医保、医疗、医药、医养等数据互联互通,推动长三角医保商保一体化服务、基层医疗服务、慢病管理服务、智慧中医药服务等创新发展。

长三角是我国经济发展最活跃、开放程度最高、创新能力最强的区域之一,三省一市不仅拥有丰富的优质医疗资源,更聚集了一批先进的数字健康企业。在今年疫情防控中,数字健康行业快速反应、高效调动资源,推动了医疗健康服务要素的深度融合和服务闭环的完善,表现出产业链融合下服务效率和体验的高质量提升。

作为行业内唯一覆盖“互联网+医疗健康”全产业链的数字健康平台,微医先后上线“新冠肺炎实时救助平台”、“全球抗疫平台”提供免费的医疗咨询服务。截至9月初,微医新冠实时救助平台已累计提供超过221万人次免费服务,总访问量超1.5亿次,全球抗疫平台获得中国170多个驻外使领馆推介,为220多个国家和地区的326万人提供防疫服务,并入选“2020长三角一体化创新成果案例”。此外,微医还在山东、天津等多地建设“数字健共体”,相继开通医保在线支付,当地居民足不出户就可以在线复诊购药。

作为重要的国家战略,长三角一体化发展为创建“长三角健共体”提供了重要机遇。“数字健康联盟是一个开放平台,持续吸纳全产业链的组织和机构加入,共同建设‘长三角健共体’,推动大数据、AI人工智能、区块链等技术在健康领域的应用和落地,共创数字健康产业生态。”数字健康联盟理事长单位相关负责人王阳博士表示,联盟的成立与发展,将助力长三角形成“共建共治共享”的医疗健康产业格局,加速“以医疗为中心”向“以健康为中心”转变,打造长三角民生幸福圈。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2007361, encodeId=2b1b200e361c7, content=<a href='/topic/show?id=8c951930466' target=_blank style='color:#2F92EE;'>#一体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19304, encryptionId=8c951930466, topicName=一体化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Dec 05 10:32:41 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741106, encodeId=521e1e411069b, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Oct 25 06:32:41 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496694, encodeId=755f149669425, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516293, encodeId=84721516293c6, content=<a href='/topic/show?id=ac9596880e3' target=_blank style='color:#2F92EE;'>#长三角#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96880, encryptionId=ac9596880e3, topicName=长三角)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57810951213, createdName=12498d2fm54(暂无昵称), createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572936, encodeId=b4bd15e293655, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890386, encodeId=a6ac89038638, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epiatfKicicDhk5vgCl5PlwhH7bTTH4KMGDd7jycjqGNe5u56EAAEPib8bRIGiaOndCPLXUf8ZiaMOFicegg/132, createdBy=82975261462, createdName=monodrama, createdTime=Tue Oct 06 17:03:42 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2007361, encodeId=2b1b200e361c7, content=<a href='/topic/show?id=8c951930466' target=_blank style='color:#2F92EE;'>#一体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19304, encryptionId=8c951930466, topicName=一体化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Dec 05 10:32:41 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741106, encodeId=521e1e411069b, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Oct 25 06:32:41 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496694, encodeId=755f149669425, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516293, encodeId=84721516293c6, content=<a href='/topic/show?id=ac9596880e3' target=_blank style='color:#2F92EE;'>#长三角#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96880, encryptionId=ac9596880e3, topicName=长三角)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57810951213, createdName=12498d2fm54(暂无昵称), createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572936, encodeId=b4bd15e293655, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890386, encodeId=a6ac89038638, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epiatfKicicDhk5vgCl5PlwhH7bTTH4KMGDd7jycjqGNe5u56EAAEPib8bRIGiaOndCPLXUf8ZiaMOFicegg/132, createdBy=82975261462, createdName=monodrama, createdTime=Tue Oct 06 17:03:42 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2007361, encodeId=2b1b200e361c7, content=<a href='/topic/show?id=8c951930466' target=_blank style='color:#2F92EE;'>#一体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19304, encryptionId=8c951930466, topicName=一体化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Dec 05 10:32:41 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741106, encodeId=521e1e411069b, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Oct 25 06:32:41 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496694, encodeId=755f149669425, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516293, encodeId=84721516293c6, content=<a href='/topic/show?id=ac9596880e3' target=_blank style='color:#2F92EE;'>#长三角#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96880, encryptionId=ac9596880e3, topicName=长三角)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57810951213, createdName=12498d2fm54(暂无昵称), createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572936, encodeId=b4bd15e293655, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890386, encodeId=a6ac89038638, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epiatfKicicDhk5vgCl5PlwhH7bTTH4KMGDd7jycjqGNe5u56EAAEPib8bRIGiaOndCPLXUf8ZiaMOFicegg/132, createdBy=82975261462, createdName=monodrama, createdTime=Tue Oct 06 17:03:42 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-07 zexyw04
  4. [GetPortalCommentsPageByObjectIdResponse(id=2007361, encodeId=2b1b200e361c7, content=<a href='/topic/show?id=8c951930466' target=_blank style='color:#2F92EE;'>#一体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19304, encryptionId=8c951930466, topicName=一体化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Dec 05 10:32:41 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741106, encodeId=521e1e411069b, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Oct 25 06:32:41 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496694, encodeId=755f149669425, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516293, encodeId=84721516293c6, content=<a href='/topic/show?id=ac9596880e3' target=_blank style='color:#2F92EE;'>#长三角#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96880, encryptionId=ac9596880e3, topicName=长三角)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57810951213, createdName=12498d2fm54(暂无昵称), createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572936, encodeId=b4bd15e293655, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890386, encodeId=a6ac89038638, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epiatfKicicDhk5vgCl5PlwhH7bTTH4KMGDd7jycjqGNe5u56EAAEPib8bRIGiaOndCPLXUf8ZiaMOFicegg/132, createdBy=82975261462, createdName=monodrama, createdTime=Tue Oct 06 17:03:42 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2007361, encodeId=2b1b200e361c7, content=<a href='/topic/show?id=8c951930466' target=_blank style='color:#2F92EE;'>#一体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19304, encryptionId=8c951930466, topicName=一体化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Dec 05 10:32:41 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741106, encodeId=521e1e411069b, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Oct 25 06:32:41 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496694, encodeId=755f149669425, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516293, encodeId=84721516293c6, content=<a href='/topic/show?id=ac9596880e3' target=_blank style='color:#2F92EE;'>#长三角#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96880, encryptionId=ac9596880e3, topicName=长三角)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57810951213, createdName=12498d2fm54(暂无昵称), createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572936, encodeId=b4bd15e293655, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890386, encodeId=a6ac89038638, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epiatfKicicDhk5vgCl5PlwhH7bTTH4KMGDd7jycjqGNe5u56EAAEPib8bRIGiaOndCPLXUf8ZiaMOFicegg/132, createdBy=82975261462, createdName=monodrama, createdTime=Tue Oct 06 17:03:42 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2007361, encodeId=2b1b200e361c7, content=<a href='/topic/show?id=8c951930466' target=_blank style='color:#2F92EE;'>#一体化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19304, encryptionId=8c951930466, topicName=一体化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Sat Dec 05 10:32:41 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741106, encodeId=521e1e411069b, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Oct 25 06:32:41 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496694, encodeId=755f149669425, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516293, encodeId=84721516293c6, content=<a href='/topic/show?id=ac9596880e3' target=_blank style='color:#2F92EE;'>#长三角#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96880, encryptionId=ac9596880e3, topicName=长三角)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57810951213, createdName=12498d2fm54(暂无昵称), createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572936, encodeId=b4bd15e293655, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Wed Oct 07 15:32:41 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890386, encodeId=a6ac89038638, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epiatfKicicDhk5vgCl5PlwhH7bTTH4KMGDd7jycjqGNe5u56EAAEPib8bRIGiaOndCPLXUf8ZiaMOFicegg/132, createdBy=82975261462, createdName=monodrama, createdTime=Tue Oct 06 17:03:42 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-06 monodrama

    0